August 9 – Walvax Biotechnology (300142.SZ) recorded a 48.24-percent year-on-year surge in net profits for the first half of 2011 to 83.85 million yuan, reports p5w.net, citing a company filing. Sale revenues during that period grew 42.64 percent year-on-year to 180 million yuan.
Welcome to our website. This service is open to member only.
Contact our customer service team
Tel: 86-10-82600828, 82600893
Fax: 86-10-82601570
Email: report@researchinchina.com